Bizarre Patents
A self defense weapon formed as a memo pad and which is easily held by a person's fingers, therefore making it possible to provide protection from a mugger and also to quickly and easily write a record or a message without failure of missing or forgetting significant information under a stressful situation.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8187889 | Protein markers for the diagnosis and prognosis of ovarian and breast cancer Plasma samples of ovarian and breast cancer patients were used to search for markers of cancer, using two-dimensional gel electrophoresis and MALDI TOF mass spectrometry. Truncated forms of cytosolic serine hydroxymethyl transferase (cSHMT), T-box transcription fact... | 05/29/2012 |
| 8173434 | PCan065 antibody compositions and methods of use The invention provides isolated anti-PCan065 antibodies that bind to PCan065. The invention also encompasses compositions comprising an anti-PCan065 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of t... | 05/08/2012 |
| 8173433 | Platelet biomarkers for cancer The present invention relates to the fields of immunology and biochemistry. Particularly, the present invention describes methods, devices and kits for early detection of clinical conditions having associated changes in systemic angiogenic activity, particularly can... | 05/08/2012 |
| 8133737 | Systems and methods for breast cancer detection and risk assessment The invention relates to a simple screening test for neoplasia, a precancerous condition, or cancer of the breast. A method is described whereby a breast cancer marker is detected in breast fluid. In a particular embodiment, the method involves treating samples of b... | 03/13/2012 |
| 8133736 | Methods for detecting or monitoring cancer using LPE as a marker A method of detecting a cancer, such as ovarian cancer, in a test subject including (a) determining the amount of a lysophosphatidyl ethanolamine in a sample of a bodily fluid taken from the test subject, and (b) comparing the amount of the lysophosphatidyl ethanola... | 03/13/2012 |
| 8067240 | Methods for the diagnosis and treatment of lung cancer The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition. ... | 11/29/2011 |
| 8062892 | Genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer The invention relates to newly discovered nucleic acid molecules and proteins associated with cervical cancer including pre-malignant conditions such as dysplasia. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human cervical... | 11/22/2011 |
| 8021886 | Method for determining whether or not a mammal is affected with a lung cancer The present disclosure relates to a method for assessing if a patient is affected with a lung cancer. The method includes analyzing the presence and amount of cyclohexanone contained in the urine excreted from the patient and determining if the presence and amount o... | 09/20/2011 |
| 8008084 | Method for determining whether or not a mammal is affected with a lung cancer The present invention relates to a method for determining whether or not a mammal is affected with a lung cancer. The method for determining whether or not a mammal is affected with a lung cancer of the present invention includes the steps of: ... | 08/30/2011 |
| 8003392 | Diagnostic test for the detection of early stage liver cancer Described are methods and kits to detect early stage hepatocellular carcinoma or a change in the gradation of hepatocellular carcinoma in mammals. The diagnostic marker is based on the profiling and identification of diagnostic carbohydrates present in a body fluid,... | 08/23/2011 |
| 8003393 | Method for determining whether or not a mammal is affected with a lung cancer The present disclosure relates to a method for assessing if a patient is affected with a lung cancer. The method includes analyzing the presence and amount of β-citronellol contained in the urine excreted from the patient and determining if the presence and amount ... | 08/23/2011 |
| 7964408 | Lysophospholipids as biomarkers of ovarian cancer A method of using a bioactive lysophospholipid (LL) as a biomarker for detecting the presence and recurrence of ovarian cancer. Subspecies of LL, such as lysophosphatidic acid (LPA), lysophosphatidylinositol (LPI), lysophosphatidylcholine (LPC), and lysosphingolipid... | 06/21/2011 |
| 7947504 | Tumor marker for pancreatic cancer and method of testing the same The determination (test, diagnosis) of pancreatic cancer can be performed with high accuracy by detecting a fucosylated sugar chain (N-glycan) present in a specific site of the human haptoglobin and using an amount of the fucosylated sugar chain as a tumor marker fo... | 05/24/2011 |
| 7883896 | Marker molecules associated with lung tumors The present invention relates to nucleic acids and polypeptides associated with lung cancer. The invention is more specifically related to a nucleic acids and the polypeptides transcribed thereof, the expression of which is significantly altered in association with ... | 02/08/2011 |
| 7879614 | Methods for detection of breast cancer The invention relates to a simple screening test for neoplasia, a precancerous condition, or cancer of the breast. A method is described whereby a breast cancer marker is detected in breast fluid. In a particular embodiment, the method involves treating samples of b... | 02/01/2011 |
| 7846737 | Genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer The invention relates to newly discovered nucleic acid molecules and proteins associated with cervical cancer including pre-malignant conditions such as dysplasia. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human cervical... | 12/07/2010 |
| 7820447 | Compositions and methods for cancer The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially lymphoma carcinomas. In addition, the present invention describes the use of novel compositions for use in screening methods. ... | 10/26/2010 |
| 7776607 | Mammalian selenoprotein differentially expressed in tumor cells A 15 kDa selenium-containing protein (“selenoprotein”) is disclosed. The protein is shown to be differentially expressed in cancer cells, such as prostate cancer cells. There is a correlation between the presence of a polymorphism at nucleotide positions 811 and... | 08/17/2010 |
| 7655471 | Biochemical markers of the human endometrium Endometrium secreted polypeptides are assayed in body fluids to determine the presence of polypeptides of specified pI and MW values that have been found to be regulated in body fluids according to the status of the endometrium, or the presence of hyperplasia or ade... | 02/02/2010 |
| 7575928 | Genes for diagnosing colorectal cancer This invention relates to provide the genes for diagnosing colorectal cancer, the gene sequences searching comprise the steps of: (1) deriving epithelium cells from normal intestines, polypus of intestines and colorectal cancer tissue; (2) collecting genes with high... | 08/18/2009 |
| 7462491 | Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin Serum cav-1 is disclosed as a biomarker for prostate cancer that has the power to differentiate between prostate cancer and BPH patients. ... | 12/09/2008 |
| 7452727 | Method for increasing clinical specificity when detecting tumors and their precursor stages by simultaneously measuring at least two different molecular markers The present invention relates to an automatable method for the improved diagnosis of pathologically altered cells by simultaneously staining at least two different molecular markers, which exhibit a change in gene expression which is disease-associated, in a cell or... | 11/18/2008 |
| 7439234 | Method for treating cancer patients undergoing chemotherapy A method for treating cancer patients undergoing chemotherapeutic treatments by administering Product R, a peptide-nucleic acid preparation, is disclosed. ... | 10/21/2008 |
| 7438890 | Binding peptides for carcinoembryonic antigen (CEA) The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isol... | 10/21/2008 |
| 7432345 | PRO1475 polypeptide The present invention is directed to novel PRO1475 polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the PRO1475 ... | 10/07/2008 |
| 7431932 | Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions Reovirus can be used to selectively remove ras-mediated neoplastic cells from a cellular composition. It is of particular interest to purge autographs which may contain neoplastic cells with reovirus before transplanting the autographs back into the recipient, there... | 10/07/2008 |
| 7429641 | PRO9830 polypeptides The present invention is directed to novel PRO9830 polypeptides chimeric polypeptide molecules comprising PRO9830 polypeptides fused to heterologous polypeptide sequences. ... | 09/30/2008 |
| 7416893 | Methods for diagnosing drug-resistant cancer cells or for identifying chemotherapeutic agents by measuring anomalous intracellular ion and/or second messenger dynamics The present invention relates to methods of identifying drug-resistant and/or drug-sensitive cells, for example, breast cancer and brain tumor cells, on the basis of different ion and/or second messenger dynamics between a drug-sensitive and drug-resistant cell. For... | 08/26/2008 |
| 7417116 | PRO7155 polypeptides The present invention is directed to novel PRO7155 polypeptides and chimeric polypeptide molecules comprising PRO7155 polypeptides fused to heterologous polypeptide sequences. ... | 08/26/2008 |
| 7416699 | Carbon nanotube devices Nanotubes and nanotube-based devices are implemented in a variety of applications. According to an example embodiment of the present invention, a nanotube is adapted to pass current between two conductive elements. In one implementation, each conductive element incl... | 08/26/2008 |
| 7411042 | Tumor associated nucleic acids and uses therefor The invention describes SAGE (sdph3.10) and sdp3.5 tumor associated nucleic acids, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acid molecules, and antibodies relating ... | 08/12/2008 |
| 7412333 | Method for prognostic factor analysis regarding cancers A method for treating a patient with cancer includes the steps of obtaining cells from a cancerous tumor in the patient. Then there is the step of performing multiple correlated measurements on each cell to obtain cell data for each cell regarding each cell's place ... | 08/12/2008 |
| 7408035 | PRO9864 polypeptides The present invention is directed to novel PRO9864 polypeptides and chimeric polypeptide molecules comprising PRO9864 polypeptides fused to heterologous polypeptide sequences. ... | 08/05/2008 |
| 7402656 | PRO10013 polypeptides The present invention is directed to novel PRO10013 polypeptides chimeric polypeptide molecules comprising PRO10013 polypeptides fused to heterologous polypeptide sequences. ... | 07/22/2008 |
| 7402403 | Tumour markers A method of determining the immune response of a mammal to circulating tumour marker proteins is described in which a sample of bodily fluid, for example plasma or serum, is contacted with a panel of two or more distinct tumour marker antigens. The presence of compl... | 07/22/2008 |
| 7402299 | Intracorporeal medicaments for photodynamic treatment of disease New intracorporeal photodynamic medicaments and certain medical uses and methods for use of such photodynamic medicaments for treatment of disease in human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthe... | 07/22/2008 |
| 7402402 | P38 MAPK pathway predicts endocrine-resistant growth of human breast cancer and provides a novel diagnostic and treatment target Acquired and de novo endocrine resistance are major clinical problems in the management of breast cancer patients. Though the antiestrogen tamoxifen prolongs disease-free and overall survival in the adjuvant setting, and induces remissions in over half of the patien... | 07/22/2008 |
| 7393685 | Method for cultivating cancer cells from human tissue and device for preparing tissue samples The invention relates to a method for cultivating cancer cells for scientific serial assays, wherein a tissue sample which is heterogeneous with respect to contaminants, normal cells and tumor cells is locally separated in a sequential-parallel splitting method. The... | 07/01/2008 |
| 7393656 | Methods and compositions for risk stratification The present invention provides an approach for the simultaneous determination of the activation states of a plurality of proteins in single cells. This approach permits the rapid detection of heterogeneity in a complex cell population based on activation states, and... | 07/01/2008 |
| 7390668 | Intracorporeal medicaments for photodynamic treatment of disease New intracorporeal photodynamic medicaments and certain medical uses and methods for use of such photodynamic medicaments for treatment of disease in human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthe... | 06/24/2008 |
